This suggests the possibility of the enteric mucosa DCs disrupting intestinal mucosal immune barrier in NASH rat model via TLR-4/MyD88 signalling pathway. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatohepatitis.